At any time, most biotech stocks can go on significant price runs, especially when news events are involved.For example, InterMune (NASDAQ: ITMN) has jumped about 35 percent today on the news that Roche has agreed to buy the company for $8.3 billion.Now, that’s a one-day pop, but which biotech stock has had the best performance over the last week?Well, the […]
The first quarter of the year brought with it some major selling in the momentum names, specifically in biotech stocks.
Since then, the overall stock market has recovered, and so have most biotech stocks with it. Unfortunately, while the market has hit new highs, most biotechs have not.
Some biotech stocks, however, have performed better than others, and some have actually outperformed […]